Delivery Order SPE2DB24D9238-SPE2DB24FDQKB

Award Date 7/8/24
Potential Completion Date 7/29/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,321.10, is for the delivery of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The delivery order, valued at $2,321.10, is for the supply of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML (NSN 4562330548) pharmaceutical products with an ultimate completion date of October 18, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,321.10, is for the supply of the pharmaceutical product XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue firm...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,160.55, is for the delivery of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a period of performance through May 14, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,605.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4564338975 XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML and has an ultimate completion date of May 6, 2024. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $4,642.20, is for the provision of XOLAIR 150 MG/ML SYRINGEML, a specialty pharmaceutical product. The delivery order was issued under a larger indefinite delivery contract (IDC) with DLA valued up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $1,934.25, is for the supply of Xolair 75 mg/0.5 ml syringes. This award is part of a larger indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, that allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $81,777 contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to place orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $13,926.60, is for the delivery of XOLAIR 150 MG/ML SYRINGEML. The contract is part of a larger indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA. This IDC allows the DLA to issue delivery orders for a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $4,642.20 and is for the delivery of the pharmaceutical product XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML. The contract is a firm fixed-price delivery order, with a period of performance through May 24, 2024. This award is associated with a larger indefinite delivery...
  • SPE2DB24D9238
    Indefinite Delivery Contract
  • SPE2DB24D9238-SPE2DB24FDQKB
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $2,321.10. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. valued at up to $499,999,999, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. The contract has a period of performance through July 29, 2024 and does not have a set-aside designation.

Generated 10/7/24, 10:45 AM